Related Experiment Video
Updated: Oct 8, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Longitudinal growth and final height in long-term survivors of childhood leukaemia
A Cicognani1, E Cacciari, P Rosito
1Clinica Pediatrica I, Bologna, Italy.
Insights
Childhood acute lymphoblastic leukemia (ALL) survivors treated with cranial irradiation experienced reduced final height, with females showing a greater height loss than males. Younger females (<4 years) at diagnosis had a more significant height deficit.
Area of Science:
- Pediatric Oncology
- Endocrinology
- Growth and Development
Background:
- Survival rates for childhood acute lymphoblastic leukemia (ALL) have improved significantly.
- Conflicting data exists regarding the long-term growth and final height of ALL survivors.
- Cranial irradiation is a common treatment modality, potentially impacting growth.
Purpose of the Study:
- To analyze the longitudinal growth and final height in survivors of childhood ALL.
- To compare growth patterns and final height outcomes based on cranial irradiation dosage.
- To investigate potential sex-based differences and age-related effects on final height.
Main Methods:
- Longitudinal height measurements were collected from 52 childhood ALL survivors (33 females, 19 males).
- Patients received cranial irradiation (2400 or 1800 cGy) and were in first remission.
- Height was measured at diagnosis, end of treatment, and at final growth completion.
Main Results:
- A significant decrease in height standard deviation score (SDS) was observed during treatment in girls, followed by a temporary catch-up growth.
- Mean final height SDS was significantly lower than at diagnosis in girls and in males treated with 2400 cGy.
- Females exhibited a greater mean overall loss in height SDS (-1.24) compared to males (-0.40); younger females (<4 years) showed a higher loss.
Conclusions:
- Childhood ALL survivors treated with cranial irradiation experience impaired final height.
- Females and younger patients at diagnosis are at higher risk for significant height deficits.
- Further research is needed to optimize growth-preserving strategies in ALL survivors.
Abstract:
Survival of children with acute lymphoblastic leukaemia (ALL) has increased considerably in recent years and data on the spontaneous growth and final height of these children are conflicting. Therefore, we analysed the longitudinal growth and final height in 52 survivors (33 females, 19 males) of childhood ALL. These children were diagnosed and treated in a single institution, all remained in first remission and were submitted to cranial irradiation with either 2400 or 1800 cGy. None of the patients received testicular or spinal irradiation. Median age at diagnosis was 4.2 (range 1.3-9.6) years in the first group (2400 cGy) and 3.9 (0.8-10.5) years in the second (1800 cGy). Standing height was measured at diagnosis, at the end of treatment (median 3.1 years after diagnosis), 6, 12, 24 months after the end of treatment, and finally at the completion of growth. In girls a significant decrease of mean height standard deviation score (SDS) during treatment and a catch up in growth after the end of therapy was followed by a second period of reduced growth. Mean final height SDS was significantly lower than the value at diagnosis in both groups of girls, but only in males treated with 2400 cGy. Mean overall loss in height SDS from diagnosis to final height was higher in females (-1.24) than in males (-0.40) (P = 0.009). Females < or = 4 years of age at diagnosis showed a higher loss in final height than females > 4 years.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
Nature and Nurture
Longitudinal Research
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Longitudinal Studies
Cancer Survival Analysis
Physical Growth During Infancy and Toddlerhood